Understanding which aspects of aneuploidy activate NF‐κB signaling and how the activity of the pathway is modulated during tumor evolution will be the critical next steps in understanding the role of aneuploidy during tumorigenesis. The gene discussed is NFKB1; the disease is neoplasm.